Hand Sanitizer WHO Recommended formula

Lords Biotech & Pharma Solutions offers a liquid hand sanitizer formulated to meet the WHO recommendation of 80 % ethanol. The product eliminates 99.9 % of microorganisms and is described as having a non‑sticky texture for comfortable hand use. It is supplied in several bottle sizes to suit different operational settings. The formulation complies with FDA regulations, providing an additional layer of assurance for buyers.

The WHO‑endorsed composition typically contains 80 % ethanol, 0.025 % hydrogen peroxide and the balance distilled water, which together ensure rapid virucidal action. In the industry, such sanitizers are classified as “medical‑grade” and are expected to maintain a pH between 7.0 and 8.0 for skin compatibility. Typical storage conditions are 15 °C to 30 °C and a shelf life of around 24 months under those conditions. The non‑sticky base is achieved by adding a small proportion of glycerol, a practice standard across reputable manufacturers.

Primary users include hospitals, clinics, schools and commercial facilities that require reliable disinfection. Bulk procurement is offered with flexible minimum order quantities, and shipments are quoted on a CIF basis to major Indian ports. Prospective importers should confirm lead times, exact pack sizes and payment terms directly with the supplier before placing an order.

Lords Biotech & Pharma Solutions is based in Thane, Maharashtra, India, at A‑5 Gulmohar CHS, Dr R P Road, Tilak Nagar, Dombivli East, PIN 421201. The company holds a harbor trust tier on the platform, indicating a basic level of verification, while its response rate is currently not recorded. It specialises in the manufacture and wholesale distribution of pharmaceutical‑grade hygiene products, including the WHO‑recommended hand sanitizer described above. The listing does not disclose specific production capacity or client portfolio.

According to the supplier profile, the firm ships products on a CIF basis and can accommodate bulk orders for distributors and institutional buyers. No explicit information on yearly turnover, employee count or certifications beyond FDA compliance is provided. Interested parties are encouraged to request samples and detailed technical data sheets to evaluate suitability. All communications should be directed to the listed address or through the platform messaging system.